1. Signaling Pathways
  2. Membrane Transporter/Ion Channel
    Neuronal Signaling
  3. iGluR
  4. NMDA Receptor Isoform
  5. NMDA Receptor Antagonist

NMDA Receptor Antagonist

NMDA Receptor Antagonists (27):

Cat. No. Product Name Effect Purity
  • HY-100806
    Kynurenic acid
    Antagonist 99.58%
    Kynurenic acid, an endogenous tryptophan metabolite, is a broad-spectrum antagonist targeting NMDA, glutamate, α7 nicotinic acetylcholine receptor.
  • HY-N0215
    L-Phenylalanine
    Antagonist 99.96%
    L-Phenylalanine ((S)-2-Amino-3-phenylpropionic acid) is an essential amino acid isolated from Escherichia coli.
  • HY-17387
    (-)-Huperzine A
    Antagonist 99.00%
    (-)-Huperzine A (Huperzine A) is an alkaloid isolated from Huperzia serrata, with neuroprotective activity.
  • HY-N2072
    Transcrocetin
    Antagonist 98.04%
    Transcrocetin (trans-Crocetin), extracted from saffron (Crocus sativus L.
  • HY-12294A
    PEAQX tetrasodium hydrate
    Antagonist ≥98.0%
    PEAQX (NVP-AAM077) tetrasodium hydrate is a potent, selective and orally active NMDA antagonist, with IC50 values of 270 nM and 29600 nM for hNMDAR 1A/2B and hNMDAR 1A/2B, respectively.
  • HY-B1270
    Isoxsuprine hydrochloride
    Antagonist 99.87%
    Isoxsuprine hydrochloride is a beta-adrenergic receptor agonist with Kis of 13.65 μΜ and 3.48 μΜ for myometrial and placcntal beta-adrenergic receptor, respectively.
  • HY-107512
    Kynurenic acid sodium
    Antagonist 99.76%
    Kynurenic acid sodium, an endogenous tryptophan metabolite, is a broad-spectrum antagonist targeting NMDA, glutamate, α7 nicotinic acetylcholine receptor.
  • HY-B0369A
    Orphenadrine citrate
    Antagonist 99.95%
    Orphenadrine citrate is an orally active and non-competitive NMDA receptor antagonist (crosses the blood-brain barrier) with a Ki of 6.0 μM.
  • HY-100714
    DL-AP5
    Antagonist ≥98.0%
    DL-AP5 (2-APV) is a competitive NMDA (N-methyl-D-aspartate) receptor antagonist.
  • HY-16502
    Transcrocetinate disodium
    Antagonist
    Transcrocetinate disodium, extracted from saffron (Crocus sativus L.
  • HY-13993
    Ro 25-6981
    Antagonist
    Ro 25-6981 is a potent, selective and activity-dependent NR2B subunit specific NMDA receptor antagonist.
  • HY-N0215S1
    L-Phenylalanine-d8
    Antagonist 99.96%
  • HY-N0215S3
    L-Phenylalanine-d2
    Antagonist 99.89%
  • HY-W001601
    Budipine
    Antagonist 99.23%
    Budipine is an anti-parkinson agent.
  • HY-N0215S12
    L-Phenylalanine-d5
    Antagonist 99.15%
  • HY-17001A
    Flupirtine
    Antagonist
    Flupirtine(D 9998) is a selective neuronal potassium channel opener that also has NMDA receptor antagonist properties.
  • HY-100806S
    Kynurenic acid-d5
    Antagonist
  • HY-N0215S
    L-Phenylalanine-d7
    Antagonist
    L-Phenylalanine-d7 ((S)-2-Amino-3-phenylpropionic acid-d7) is the deuterium labeled L-Phenylalanine.
  • HY-N0215S11
    L-Phenylalanine-13C9,15N
    Antagonist
    L-Phenylalanine-13C9,15N ((S)-2-Amino-3-phenylpropionic acid-13C9,15N) is the 13C- and 15N-labeled L-Phenylalanine.
  • HY-N0215S7
    L-Phenylalanine-3-13C
    Antagonist